BIOLASE (NASDAQ:BIOL) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note published on Thursday. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Trading Down 1.1 %

BIOLASE stock opened at $0.01 on Thursday. BIOLASE has a 52 week low of $0.02 and a 52 week high of $1.94. The stock has a market cap of $247,712.91, a P/E ratio of 0.00 and a beta of 0.67. The stock has a 50 day moving average of $0.01 and a 200-day moving average of $0.02.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.